CUV 0.85% $15.37 clinuvel pharmaceuticals limited

fantastic news!!!! This is a cut and paste of a post by...

  1. 162 Posts.
    fantastic news!!!! This is a cut and paste of a post by polyphemus at SS forum. This guy really knows his stuff and is in nooooo way a ramper....please read and digest. I am much much happier now this has been posted.


    Fantastic News - the way it should have been done in the first place.
    Lets look at the math and I will be conservative.

    Previously
    1 /2 Yr figures has NTA at 11c
    Remove the $4m in intangible assets and the correct figure is 10.3m /128m share = 8c per share
    Share Price has been running at multiples of 8-10 versus assets.

    Now
    A conservative issue ar 50c AUD to raise $37m AUD needs 74million shares.
    New shares on Issue 202 million New Tangible Assets $37m AUD + Existing $8m or $45m AUD

    Now applying the same price to asset model that EPT has been running at say 8:1
    8*45m = $360m valuation devide the number of shares 202 and you get a share price of $1.78

    Now I was told the issue was in May - so a $1 rise in price is pretty good.

    Move on 3 years. Sales of 4billion with a 50% cut not the 5-10% a pharma would offer. Earnings of $2billion AUD. Minus tax avg Aust coy tax paid is 27% = 1.5Billion AUD
    Pay 60% or 900million in dividend = $4.45 fully franked Use a 5% yield market average so multiply your $4.45*20 = $89 AUD - now these figures are conservative and it all starts with an issue to raise money and phase 3 trials being dine in Europe. We can sell to the americans over the internet as the topical formulation may work.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.37
Change
0.130(0.85%)
Mkt cap ! $770.0M
Open High Low Value Volume
$15.36 $15.54 $15.18 $1.274M 82.63K

Buyers (Bids)

No. Vol. Price($)
1 237 $15.31
 

Sellers (Offers)

Price($) Vol. No.
$15.50 282 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.